NCT04349722View on ClinicalTrials.gov

The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Labor Long
Interventions
DRUG

Hyoscine Butylbromide

Intervention is given once a participant is in established labor

OTHER

Placebo

Intervention is given once a participant is in established labor

Trial Locations (1)

56000

National University Malaysia Medical Centre, Cheras

All Listed Sponsors
lead

National University of Malaysia

OTHER

NCT04349722 - The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae | Biotech Hunter | Biotech Hunter